Clinical Trial: Treatment of Spastic Equinovarus Foot After Stroke

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: Treatment of Spastic Equinovarus Foot After Stroke. Efficacy: Association Between Ankle Foot Orthosis and Botulinum Toxin A (BTA) Injection

Brief Summary: This study evaluates treatment for spastic foot after stroke using ankle foot orthosis with or without selective injection of BTA (Botox).

Detailed Summary: This prospective, multicentric open trial evaluates the efficacy of a combined treatment for spastic foot after stroke using ankle foot orthosis with or without selective injection of BTA (Botox) into the tibialis anterior and/or posterior and/or the long toe flexor, and/or medial and lateral gastrocnemius, and/or soleus muscles [300 BTA U per injection (Botox - Allergan), diluted with saline to a concentration of 5U/0,1 mL, with electromyography guided injection]. The patients are followed for one year after treatment.
Sponsor: University Hospital, Limoges

Current Primary Outcome: Plantar contact during walking

Original Primary Outcome: - Plantar contact during walking

Current Secondary Outcome:

  • Gait velocity
  • Barthel index
  • MIF
  • Autosatisfaction by EVA
  • Asworth scale
  • Ankle range of motion


Original Secondary Outcome:

  • Gait velocity
  • Barthel index
  • MIF
  • Autosatisfaction by EVA
  • Asworth scale
  • -ankle range of motion.


Information By: University Hospital, Limoges

Dates:
Date Received: September 14, 2005
Date Started: October 2002
Date Completion:
Last Updated: December 29, 2008
Last Verified: December 2008